Robert Alexander Ingram Black Diamond Therapeutics, Inc. (BDTX) insider trading activity

Robert Alexander Ingram is of Black Diamond Therapeutics, Inc.. Currently has a direct ownership of 42,854 shares of BDTX, which is worth approximately $93,421. The most recent transaction as insider was on Dec 16, 2022, when has been sold 9,375 shares (Common Stock) at a price of $1.5 per share, resulting in proceeds of $14,062. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 42.9K

0% 3M change

0% 12M change

Total Value Held $93,421

ROBERT ALEXANDER INGRAM Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 16 2022	BUY Grant, award, or other acquisition	$14,062 $1.5 p/Share	9,375 Added 17.95%	42,854 Common Stock
Sep 16 2022	BUY Grant, award, or other acquisition	$17,250 $2.62 p/Share	6,584 Added 16.43%	33,479 Common Stock
Jun 17 2022	BUY Grant, award, or other acquisition	$17,251 $2.03 p/Share	8,498 Added 24.01%	26,895 Common Stock
Mar 18 2022	BUY Grant, award, or other acquisition	$17,501 $3.02 p/Share	5,795 Added 23.95%	18,397 Common Stock
Dec 17 2021	BUY Grant, award, or other acquisition	$17,502 $5.31 p/Share	3,296 Added 20.73%	12,602 Common Stock
Sep 17 2021	BUY Grant, award, or other acquisition	$18,503 $9.9 p/Share	1,869 Added 16.72%	9,306 Common Stock
Jun 18 2021	BUY Grant, award, or other acquisition	$16,252 $12.95 p/Share	1,255 Added 14.44%	7,437 Common Stock
Mar 18 2021	BUY Grant, award, or other acquisition	$16,255 $24.01 p/Share	677 Added 9.87%	6,182 Common Stock
Dec 15 2020	BUY Grant, award, or other acquisition	$17,316 $34.29 p/Share	505 Added 8.4%	5,505 Common Stock
Sep 30 2020	BUY Open market or private purchase	$152,300 $30.46 p/Share	5,000 Added 50.0%	5,000 Common Stock

Also insider at

BCRX

BIOCRYST PHARMACEUTICALS INC Healthcare

Director

RAI